Skip to main content

Global Advanced Balloon Catheter Market Witnessing A CAGR of 6.25% During the Forecast Period 2021-2030

 According to a new market intelligence report by BIS Research titled ‘Global Advanced Balloon Catheter Market − Analysis and Forecast, 2021-20230’, In the pre-COVID-19 scenario the global advanced balloon catheter market was valued at $2,523.9 million in 2019 and was anticipated to reach up to $4405.3 million in 2030 witnessing a CAGR of 6.25% during the forecast period 2021-2030.


BIS Research Report: https://bisresearch.com/industry-report/advanced-balloon-catheter-market.html


The global advanced balloon catheter market is driven by various factors, such as the increasing prevalence of CVDs and PAD, rising demand for minimally invasive procedures, advancements in balloon catheters, and the favorable reimbursement landscape in developed economies. The driving factors are anticipated to propel the growth of the market during the forecast 2021-2030.


The global advanced balloon catheter industry comprises various stakeholders, namely, balloon catheter manufacturers, distributors, and regulators. The stakeholders are responsible for the manufacturing, distribution, approval, and regulation of the balloon catheters available in the market.


Request for Sample Report:  https://bisresearch.com/requestsample?id=1012&type=download


The global advanced balloon catheter market is consolidated in nature with companies such as Boston Scientific Corporation, Terumo Corporation, Medtronic plc, Abbott Laboratories, B.Braun Melsungen AG, Koninklijke Philips N.V., Becton, Dickinson and Company (BD), holding 65.50% share in the overall market cumulatively.


Key Questions Answered in this Report:


•    How has the COVID-19 pandemic impacted the global advanced balloon catheter market?


•    What is the adoption rate of the balloon catheters in peripheral artery disease (PAD) and coronary artery disease (CAD) across various regions?


•    What is the reimbursement landscape for the balloon catheters across various regions?


•    How does the regulatory landscape for the balloon catheters impact the overall global advanced balloon catheter market?


•    Who are the key players in the global advanced balloon catheters and their respective market share?

About BIS Research:

BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends which are likely to disrupt the dynamics of the market.

With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials and Chemicals, Aerospace and Defense, Automotive, Healthcare, Electronics and Semiconductors, Robotics and UAV, and other emerging technologies.

Our in-depth market intelligence reports focus on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.

What distinguishes BIS Research from the rest of the players is that we don’t simply provide data but also complement it with valuable insights and actionable inputs for the success of our clients.










 

Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

  PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market   are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...
Post a Comment
Read more

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: •     Industry Analysis    ...
Post a Comment
Read more